Mu-opioid receptors are involved in the tolerance to nicotine antinociception

Lola Galeote1, Brigitte L Kieffer, Rafael Maldonado

  • 1Laboratori de Neurofarmacologia, Facultat de Ciències de la Salut i de la Vida, Universitat Pompeu Fabra, Barcelona, Spain. rafael.maldonado@upf.edu

Insights

Mu-opioid receptors are involved in nicotine tolerance. While their density changed in some brain areas, their spinal cord activity increased, suggesting a complex role in developing tolerance to nicotine

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • The endogenous opioid system influences nicotine's effects on pain and addiction.
  • Understanding the role of specific opioid receptors, like mu-opioid receptors, is crucial for elucidating nicotine's mechanisms of action.

Purpose of the Study:

  • To investigate the involvement of mu-opioid receptors in the development of tolerance to nicotine's antinociceptive effects.
  • To explore adaptive changes in mu-opioid receptor expression and function following chronic nicotine exposure.

Main Methods:

  • Chronic nicotine administration to C57BL/6 mice to induce tolerance.
  • Autoradiography using [(3)H]DAMGO to assess mu-opioid receptor density.
  • Guanosine [(35)S]5'-(gamma-thio)-triphosphate ([(35)S]GTPgammaS) binding assays to measure receptor functional activity.
  • Evaluation of nicotine-induced antinociception in mu-opioid receptor knockout mice.

Main Results:

  • Chronic nicotine treatment led to tolerance in the tail-immersion test.
  • Mu-opioid receptor density decreased in the caudate-putamen and nucleus accumbens but remained unchanged in the spinal cord.
  • Functional activity of spinal mu-opioid receptors significantly increased after nicotine treatment.
  • Tolerance to nicotine's antinociceptive effects developed faster in mu-opioid receptor knockout mice compared to wild-type.

Conclusions:

  • Mu-opioid receptors play a significant role in the development of tolerance to nicotine's antinociceptive effects.
  • Adaptive changes in mu-opioid receptor function, particularly in the spinal cord, contribute to nicotine tolerance.
  • The absence of mu-opioid receptors accelerates the development of nicotine tolerance, highlighting their modulatory role.

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...